← Back to Patent Explorer
US4239780A Expired / Lapsed US ⏱️ 0.0 years remaining

Phospholipase A2 inhibition

Assignee: Pharmacia and Upjohn Co
•
Filing: 1979-10-11
•
Granted: 1980-12-16
•
Expires: 1999-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Phospholipase A 2 inhibition the present invention relates to a method for treating or preventing a phospholipase A 2 mediated condition (PMC) in a mammal suffering from or susceptible to such a condition. The method involves administering to such a mammal an amount effective to treat the condition of a compound selected from a certain group of butyrophenones.

Inventors

  • 👤 Donald P. Wallach

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 04:08
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 95 words
A method for treating a phospholipase A 2 mediated condition (PMC) in a mammal suffering from the development of said PMC which comprises administering to said mammal an amount of a compound of formula I: wherein R 1 is R 1 --N(R 3 )--CH 2 --CH 2 --CH 2 --R 2 ##STR16## R 2 is ##STR17## R 3 is H or CH 3 , with the proviso that R 3 is -CH 3 only when R 1 is ##STR18## or a pharmacologically acceptable acid addition salt or salt hydrate thereof, effective to treat said PMC.
Claim 2
Independent Claim 95 words
A method for treating a phospholipase A 2 mediated condition (PMC) in a mammal suffering from the development of said PMC which comprises administering to said mammal an amount of a compound of formula I: wherein R 1 is R 1 --N(R 3 )--CH 2 --CH 2 --CH 2 --R 2 ##STR16## R 2 is ##STR17## R 3 is H or CH 3 , with the proviso that R 3 is -CH 3 only when R 1 is ##STR18## or a pharmacologically acceptable acid addition salt or salt hydrate thereof, effective to treat said PMC.

References Cited (Backward Citations)

US3979444A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-12-16 1984-06-16 1984-12-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-12-16 1988-06-16 1988-12-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-12-16 1992-06-16 1992-12-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag